ASH2L and hepatocellular carcinoma: Moreover, mutation at position 312 of ASH2L significantly diminished the ability of AARS1 to enhance VEGFA expression in HCC cells, indicating that AARS1 promoted angiogenesis in liver cancer through ASH2L lactylation (Figure S3H–K, Supporting Information).